Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Journal of Pediatrics
Erschienen in: European Journal of Pediatrics 12/2010

01.12.2010 | Review

EPONYM

Sweet syndrome

verfasst von: Mi Jin Kim, Yon Ho Choe

Erschienen in: European Journal of Pediatrics | Ausgabe 12/2010

Einloggen, um Zugang zu erhalten

Abstract

Sweet syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by tender, red inflammatory nodules or papules that occur in association with infection, malignancy, connective tissue disease, or following exposure to certain drugs. Although drug-induced Sweet syndrome is rare, granulocyte colony-stimulating factor, all-trans-retinoic acid, and miscellaneous drugs have been implicated in causing this disorder in adults. In pediatric patients, granulocyte colony-stimulating factor, all-trans-retinoic acid, trimethoprim-sulfamethoxazole, and azathioprine have been implicated as potential causes of drug-induced Sweet syndrome. To date, six cases, including the patient reported here, have been reported in children.
Literatur
1.
Abecassis S, Ingen-Housz-Oro S, Cavelier-Balloy B et al (2004) Particular histological features of a case of Sweet’s syndrome induced by G-CSF. Ann Dermatol Vénéréol 131:369–372CrossRefPubMed
2.
Aguiar-Bujanda D, Aguiar-Morales J, Bohn-Sarmiento U (2004) Sweet’s syndrome associated with norfloxacin in a prostate cancer patient. QJM 97:55–56CrossRefPubMed
3.
Ahn SJ, Choi JH, Sung KJ et al (2000) Sweet’s syndrome presenting with lesions resembling eruptive xanthoma. Br J Dermatol 143:449–450CrossRefPubMed
4.
Al-Saad K, Khanani MF, Naqvi A et al (2004) Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pediatr Hematol Oncol 26:197–199CrossRefPubMed
5.
Alvaro T, Garcia del Moral R, Gomez-Morales M et al (1991) Immunopathological studies of Sweet’s syndrome. Br J Dermatol 124:111–112CrossRefPubMed
6.
Arbetter KR, Hubbard KW, Markovic SN et al (1999) Case of granulocyte colony-stimulating factor-induced Sweet’s syndrome. Am J Hematol 61:126–129CrossRefPubMed
7.
Bianchi L, Masi M, Hagman JH et al (1999) Systemic interferon-alpha treatment for idiopathic Sweet’s syndrome. Clin Exp Dermatol 24:443–445CrossRefPubMed
8.
Bidyasar S, Montoya M, Suleman K et al (2008) Sweet syndrome associated with granulocyte colony-stimulating factor. J Clin Oncol 26:4355–4356CrossRefPubMed
9.
Boatman BW, Taylor RC, Klein LE et al (1994) Sweet’s syndrome in children. South Med J 87:193–196CrossRefPubMed
10.
Christ E, Linka A, Jacky E et al (1996) Sweet’s syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. Leukemia 10:731–734PubMed
11.
Cobb MW (1989) Furosemide-induced eruption simulating Sweet’s syndrome. J Am Acad Dermatol 21:339–343CrossRefPubMed
12.
Cohen PR (2007) Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2:34CrossRefPubMed
13.
Cohen PR, Almeida L, Kurzrock R (1989) Acute febrile neutrophilic dermatosis. Am Fam Physician 39:199–204PubMed
14.
15.
Cohen PR, Kurzrock R (2000) Sweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol 18:265–282CrossRefPubMed
16.
Cohen PR, Kurzrock R (2003) Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol 42:761–778CrossRefPubMed
17.
Cohen PR, Talpaz M, Kurzrock R (1988) Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol 6:1887–1897PubMed
18.
Corbett M, Schlup M (2001) Azathioprine hypersensitivity mimicking underlying inflammatory bowel disease. Intern Med J 31:366–367CrossRefPubMed
19.
Cox NH, O’Brien HA (1994) Sweet’s syndrome associated with trans-retinoic acid treatment in acute promyelocytic leukaemia. Clin Exp Dermatol 19:51–52CrossRefPubMed
20.
de Fonclare AL, Khosrotehrani K, Aractingi S et al (2007) Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease. Arch Dermatol 143:744–748CrossRefPubMed
21.
Del Giudice P, Vandenbos F, Perrin C et al (2004) Sweet’s syndrome following abacavir therapy. J Am Acad Dermatol 51:474–475CrossRefPubMed
22.
Dunn TR, Saperstein HW, Biederman A et al (1992) Sweet syndrome in a neonate with aseptic meningitis. Pediatr Dermatol 9:288–292CrossRefPubMed
23.
El-Azhary RA (2003) Azathioprine: current status and future considerations. Int J Dermatol 42:335–341CrossRefPubMed
24.
El-Azhary RA, Brunner KL, Gibson LE (2008) Sweet syndrome as a manifestation of azathioprine hypersensitivity. Mayo Clin Proc 83:1026–1030CrossRefPubMed
25.
Fett DL, Gibson LE, Su WP (1995) Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 70:234–240CrossRefPubMed
26.
Fitzgerald RL, McBurney EI, Nesbitt LT Jr (1996) Sweet’s syndrome. Int J Dermatol 35:9–15CrossRefPubMed
27.
Fye KH, Crowley E, Berger TG et al (2001) Celecoxib-induced Sweet’s syndrome. J Am Acad Dermatol 45:300–302CrossRefPubMed
28.
Garey KW, Streetman DS, Rainish MC (1998) Azathioprine hypersensitivity reaction in a patient with ulcerative colitis. Ann Pharmacother 32:425–428CrossRefPubMed
29.
Garty BZ, Levy I, Nitzan M et al (1996) Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type Ib. Pediatrics 97:401–403PubMed
30.
Gilmour E, Chalmers RJ, Rowlands DJ (1995) Drug-induced Sweet’s syndrome (acute febrile neutrophilic dermatosis) associated with hydralazine. Br J Dermatol 133:490–491CrossRefPubMed
31.
Ginarte M, Garcia Doval I, Toribio J (1997) Sweet’s syndrome: a study of 16 cases. Med Clin (Barc) 109:588–591
32.
Going JJ, Going SM, Myskow MW et al (1987) Sweet’s syndrome: histological and immunohistochemical study of 15 cases. J Clin Pathol 40:175–179CrossRefPubMed
33.
Gray LC, Abele DC (1998) Annular erythematous plaques and tibial pain in a child. Sweet syndrome. Arch Dermatol 134(625–626):628–629
34.
Guimera FJ, Garcia-Bustinduy M, Noda A et al (2000) Diazepam-associated Sweet’s syndrome. Int J Dermatol 39:795–798CrossRefPubMed
35.
Gyorfy A, Kovacs T, Szegedi I et al (2003) Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy. Med Pediatr Oncol 40:135–136CrossRefPubMed
36.
Halpern J, Salim A (2009) Pediatric sweet syndrome: case report and literature review. Pediatr Dermatol 26:452–457CrossRefPubMed
37.
Howard R, Tsuchiya A (1998) Adult skin disease in the pediatric patient. Dermatol Clin 16:593–608CrossRefPubMed
38.
39.
Jordaan HF (1989) Acute febrile neutrophilic dermatosis. A histopathological study of 37 patients and a review of the literature. Am J Dermatopathol 11:99–111CrossRefPubMed
40.
Klock JC, Oken RL (1976) Febrile neutrophilic dermatosis in acute myelogenous leukemia. Cancer 37:922–927CrossRefPubMed
41.
Knowles S, Shear NH (1997) Azathioprine hypersensitivity reactions: caution upon rechallenge. Muscle Nerve 20:1467–1468CrossRefPubMed
42.
Kumar G, Bernstein JM, Waibel JS et al (2004) Sweet’s syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment. Am J Hematol 76:283–285CrossRefPubMed
43.
Magro CM, Crowson AN (1997) A distinctive vesiculopustular eruption associated with hepatobiliary disease. Int J Dermatol 36:837–844CrossRefPubMed
44.
Majeed HA, Kalaawi M, Mohanty D et al (1989) Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr 115:730–734CrossRefPubMed
45.
McGovern DP, Travis SP, Duley J et al (2002) Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity. Gastroenterology 122:838–839CrossRefPubMed
46.
McLeod HL, Krynetski EY, Relling MV et al (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14:567–572CrossRefPubMed
47.
Mensing H, Kowalzick L (1991) Acute febrile neutrophilic dermatosis (Sweet’s syndrome) caused by minocycline. Dermatologica 182:43–46CrossRefPubMed
48.
Miller RM, Darben TA, Nedwich J et al (1999) Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves’ disease and a neutrophilic dermatosis. Br J Dermatol 141:943–944CrossRefPubMed
49.
Morgan KW, Callen JP (2001) Sweet’s syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells. J Am Acad Dermatol 45:590–595CrossRefPubMed
50.
Noda K, Okuma Y, Fukae J et al (2001) Sweet’s syndrome associated with encephalitis. J Neurol Sci 188:95–97CrossRefPubMed
51.
Otheo E, Ros P, Vazquez JL et al (2002) Systemic inflammatory response syndrome associated with Sweet’s syndrome. Pediatr Crit Care Med 3:190–193CrossRefPubMed
52.
Ozdemir D, Korkmaz U, Sahin I et al (2006) Ofloxacin induced Sweet’s syndrome in a patient with Crohn’s disease. J Infect 52:e155–e157CrossRefPubMed
53.
Paoluzi OA, Crispino P, Amantea A et al (2004) Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet’s syndrome. Case report and review of literature. Dig Liver Dis 36:361–366CrossRefPubMed
54.
Parsapour K, Reep MD, Gohar K et al (2003) Familial Sweet’s syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol 49:132–138CrossRefPubMed
55.
Piette WW, Trapp JF, O’Donnell MJ et al (1994) Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy. J Am Acad Dermatol 30:293–297CrossRefPubMed
56.
Retief CR, Malkinson FD (1999) Nitrofurantoin-associated Sweet’s syndrome. Cutis 63:177–179PubMed
57.
Sarkany RP, Burrows NP, Grant JW et al (1998) The pustular eruption of ulcerative colitis: a variant of Sweet’s syndrome? Br J Dermatol 138:365–366CrossRefPubMed
58.
Saxe N, Gordon W (1978) Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Four case reports. S Afr Med J 53:253–256PubMed
59.
Schonfeldt-Lecuona C, Connemann BJ (2002) Sweet’s syndrome and polyserositis with clozapine. Am J Psychiatry 159:1947CrossRefPubMed
60.
Shimizu T, Yoshida I, Eguchi H et al (1996) Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony-stimulating factor. J Pediatr Hematol Oncol 18:282–284CrossRefPubMed
61.
Sinico RA, Sabadini E, Borlandelli S et al (2003) Azathioprine hypersensitivity: report of two cases and review of the literature. J Nephrol 16:272–276PubMed
62.
Sitjas D, Puig L, Cuatrecasas M et al (1993) Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Int J Dermatol 32:261–268CrossRefPubMed
63.
Su WP, Liu HN (1986) Diagnostic criteria for Sweet’s syndrome. Cutis 37:167–174PubMed
64.
65.
Tefany FJ, Georgouras K (1991) A neutrophilic reaction of Sweet’s syndrome type associated with the oral contraceptive. Australas J Dermatol 32:55–59CrossRefPubMed
66.
Thibault MJ, Billick RC, Srolovitz H (1992) Minocycline-induced Sweet’s syndrome. J Am Acad Dermatol 27:801–804CrossRefPubMed
67.
Thompson DF, Montarella KE (2007) Drug-induced Sweet’s syndrome. Ann Pharmacother 41:802–811CrossRefPubMed
68.
Thompson MA, Dyson SW, Faderl S (2006) Sweet’s syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor. Am J Hematol 81:703–705CrossRefPubMed
69.
Tomas JF, Escudero A, Fernandez-Ranada JM (1994) All-trans retinoic acid treatment and Sweet syndrome. Leukemia 8:1596PubMed
70.
Uhara H, Saida T, Nakazawa H et al (2008) Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor. J Am Acad Dermatol 59:S10–S12CrossRefPubMed
71.
Veres K, Haraszti A, Nemes Z et al (1999) Sweet syndrome following therapeutic use of granulocyte colony stimulating factor. Orv Hetil 140:1059–1061PubMed
72.
von den Driesch P (1994) Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31:535–556, quiz 557–560CrossRefPubMed
73.
Walker DC, Cohen PR (1996) Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol 34:918–923CrossRefPubMed
74.
White JM, Mufti GJ, Salisbury JR et al (2006) Cutaneous manifestations of granulocyte colony-stimulating factor. Clin Exp Dermatol 31:206–207CrossRefPubMed
75.
Yiasemides E, Thom G (2009) Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis. Australas J Dermatol 50:48–51CrossRefPubMed
76.
Ytting H, Vind I, Bang D et al (2005) Sweet’s syndrome-an extraintestinal manifestation in inflammatory bowel disease. Digestion 72:195–200CrossRefPubMed
Metadaten
Titel
EPONYM
Sweet syndrome
verfasst von
Mi Jin Kim
Yon Ho Choe
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 12/2010
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-010-1201-z

Weitere Artikel der Ausgabe 12/2010

European Journal of Pediatrics 12/2010 Zur Ausgabe

Short Report

Post-mortem MRI reveals CPT2 deficiency after sudden infant death

Short Report

Too much of too little: xylitol, an unusual trigger of a chronic metabolic hyperchloremic acidosis

Original Paper

Gómez–López-Hernández syndrome: reappraisal of the diagnostic criteria

Original Paper

Pain reduction in children during port-à-cath catheter puncture using local anaesthesia with EMLA™

Original Paper

Intussusception-associated hospitalisations in Southern Germany

Original Paper

Maternal stress induces long-lasting Purkinje cell developmental impairments in mouse offspring

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise